Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments

被引:64
作者
de Fromentel, CC
Gruel, N
Venot, C
Debussche, L
Conseiller, E
Dureuil, C
Teillaud, JL
Tocque, B
Bracco, L
机构
[1] Rhone Poulenc Rorer SA, Gene Med Dept, F-94403 Vitry, France
[2] Inst Curie, Lab Biotechnol Anticorps, F-75005 Paris, France
[3] Inst Curie, U255, INSERM, F-75005 Paris, France
关键词
p53; scFv; intracellular immunization; gene therapy;
D O I
10.1038/sj.onc.1202338
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the production and the properties of single chain Fv fragments (scFvs) derived from the anti-p53 monoclonal antibodies PAb421 and 11D3, 11D3 is a newly generated monoclonal antibody which exhibits properties very comparable to those of PAb421, The scFvs PAb421 and 11D3 are able to stably associate with p53 and to restore the DNA binding activity of some p53 mutants in vitro. When expressed in p53(-/-) human tumour cells, the scFv421 is essentially localized in the cytoplasm in the absence of p53, and in the nucleus when exogenous p53 is present, Thus, p53 is also able to stably associate with an anti-p53 scFv in cells. Cotransfection of p53(-/-) human tumour cells with expression vectors encoding the His273 p53 mutant and either scFv leads to restoration of the p53 mutant deficient transcriptional activity. These data demonstrate that, in human tumour cells, these scFvs are able to restore a function essential for the tumour suppressor activity of p53 and may represent a novel class of molecules for p53-based cancer therapy.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 49 条
  • [1] ABARZUA P, 1995, CANCER RES, V55, P3490
  • [2] Abarzua P, 1996, ONCOGENE, V13, P2477
  • [3] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [4] THE CARBOXYL-TERMINAL DOMAIN OF THE P53 PROTEIN REGULATES SEQUENCE-SPECIFIC DNA-BINDING THROUGH ITS NONSPECIFIC NUCLEIC ACID-BINDING ACTIVITY
    BAYLE, JH
    ELENBAAS, B
    LEVINE, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5729 - 5733
  • [5] INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53
    BUCKBINDER, L
    TALBOTT, R
    VELASCOMIGUEL, S
    TAKENAKA, I
    FAHA, B
    SEIZINGER, BR
    KLEY, N
    [J]. NATURE, 1995, 377 (6550) : 646 - 649
  • [6] BYK G, 1995, Patent No. 01865
  • [7] P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES
    CAELLES, C
    HELMBERG, A
    KARIN, M
    [J]. NATURE, 1994, 370 (6486) : 220 - 223
  • [8] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS
    CLARKE, AR
    PURDIE, CA
    HARRISON, DJ
    MORRIS, RG
    BIRD, CC
    HOOPER, ML
    WYLLIE, AH
    [J]. NATURE, 1993, 362 (6423) : 849 - 852
  • [9] Cochet O, 1998, CANCER RES, V58, P1170
  • [10] DIRECT INVOLVEMENT OF P53 IN PROGRAMMED CELL-DEATH OF OLIGODENDROCYTES
    EIZENBERG, O
    FABERELMAN, A
    GOTTLIEB, E
    OREN, M
    ROTTER, V
    SCHWARTZ, M
    [J]. EMBO JOURNAL, 1995, 14 (06) : 1136 - 1144